Alector (ALEC) Change in Receivables (2018)

Alector (ALEC) reported Change in Receivables of -$169000.0 for Q2 2018, down 144.93% quarter-over-quarter from -$69000.0 in Q1 2018.

Alector (ALEC) Change in Receivables (2018) Analysis & Trends

Alector (ALEC) has 1 years of Change in Receivables data on file, last reported at -$169000.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	22,529.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-39.80 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-4.08 Mn
10	Alector	193.53 Mn	-12.98 Mn	-	-

Download Data